Literature DB >> 21093902

Value-based medicine pricing: NICE work?

David J Webb1.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 21093902     DOI： 10.1016/S0140-6736(10)62137-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Role of centralized review processes for making reimbursement decisions on new health technologies in Europe.

Authors:  Tania Stafinski; Devidas Menon; Caroline Davis; Christopher McCabe
Journal:  Clinicoecon Outcomes Res       Date:  2011-08-30

2.  UK medicines policy: the role of clinical pharmacologists.

Authors:  David J Webb
Journal:  Br J Clin Pharmacol       Date:  2012-06       Impact factor: 4.335

3.  Promoting networks between evidence-based medicine and values-based medicine in continuing medical education.

Authors:  Myriam M Altamirano-Bustamante; Nelly F Altamirano-Bustamante; Alberto Lifshitz; Ignacio Mora-Magaña; Adalberto de Hoyos; María Teresa Avila-Osorio; Silvia Quintana-Vargas; Jorge A Aguirre; Jorge Méndez; Chiharu Murata; Rodrigo Nava-Diosdado; Oscar Martínez-González; Elisa Calleja; Raúl Vargas; Juan Manuel Mejía-Arangure; Araceli Cortez-Domínguez; Fernand Vedrenne-Gutiérrez; Perla Sueiras; Juan Garduño; Sergio Islas-Andrade; Fabio Salamanca; Jesús Kumate-Rodríguez; Alejandro Reyes-Fuentes
Journal:  BMC Med       Date:  2013-02-15       Impact factor: 8.775

Review 4.  Health economic evaluation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma: a systematic review.

Authors:  Haiyin Wang; Chunlin Jin; Liang Fang; Hui Sun; Wendi Cheng; Shanlian Hu
Journal:  Cost Eff Resour Alloc       Date:  2020-01-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.